Epigral Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 08, 2026
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Epigral Limited has submitted to NSE a disclosure regarding the proceedings of its Annual General Meeting (AGM) held on June 8, 2026. This is a standard compliance filing made after the conclusion of the AGM, where the company shares details of the meeting including resolutions put to vote, voting results, and any key items discussed or approved by shareholders. The headline itself does not specify the agenda items, resolutions passed, or voting outcomes, which are typically attached as an annexure to the filing.
This is a routine regulatory filing with no direct impact on share price. Investors should review the detailed voting results and approved resolutions (such as dividend, director appointments, or financial statements) for any meaningful signals. Any material decisions from the AGM would have already been communicated via prior filings.